Skip to main content

Alexander Cappello and Sara Cunningham


Benitec said last week that it has appointed Alexander Cappello to its board of directors.

Cappello is chairman, CEO, and co-founder of the Cappello Capital, an investment banking firm and strategic advisor to Benitec.

Prior to founding Cappello Capital, Cappello founded the Cappello Group, a parent to the merchant and banking firms Swiss American Financial and Euro American Financial.

Cappello holds a BS from the Marshall School of Business at the University of Southern California.

Benitec also announced this week that Sara Cunningham has been confirmed as the CEO of the company after assuming the role of acting CEO following the resignation of John McKinley (see RNAi News, 1/21/2005).

Cunningham has also been appointed to the company’s board of directors.

Before founding Avocel, an RNAi firm acquired by Benitec, Cunningham held positions at BD Biosciences and Clontech.


The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.